Form 4 for PSNL Personalis, Inc.
Accepted 2024-08-20 00:00:00 ET · period of report 2024-08-16 · accession 0001493152-24-033271 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-20 | 2024-08-16 | PSNL | Tempus AI, Inc. | 10% | P - Purchase | $5.07 | +3.50M | 12.72M | +38% | +$17.75M |
| DM | 2024-08-20 | 2024-08-16 | PSNL | Tempus AI, Inc. | 10% | X - OptEx | $2.00 | +9.22M | 4.61M | New | +$18.44M |
| DM | 2024-08-20 | 2024-08-16 | PSNL | Tempus AI, Inc. | 10% | X - OptEx | — | -9.22M | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-16 | P | A | 3,500,000 | $5.07 | 12,718,800 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-16 | X | A | 4,609,400 | $2.50 | 9,218,800 | D | — | — | |
| 3 | Common | Common Stock | 2024-08-16 | X | A | 4,609,400 | $1.50 | 4,609,400 | D | — | — | |
| 4 | Derivative | Warrant (Right to Buy) | 2024-08-16 | X | D | 4,609,400 | — | 0 | D | $2.50 · 2023-11-28 to 2025-12-31 | 4,609,400 Common Stock | (F1) The Reporting Person acquired the warrants as partial consideration for its obligations to the Issuer under that certain Commercialization and Reference Laboratory Agreement, dated November 25, 2023, between the Issuer and the Reporting Person. |
| 5 | Derivative | Warrant (Right to Buy) | 2024-08-16 | X | D | 4,609,400 | — | 0 | D | $1.50 · 2023-11-28 to 2024-12-31 | 4,609,400 Common Stock | (F1) The Reporting Person acquired the warrants as partial consideration for its obligations to the Issuer under that certain Commercialization and Reference Laboratory Agreement, dated November 25, 2023, between the Issuer and the Reporting Person. |